What is the ROE (Return on Equity) of Surmodics this year?
The ROE of Surmodics this year is -0.01 undefined.
Surmodics ROE 2024
Surmodics ROE
-0.01
Ticker
SRDX
ISIN
US8688731004
WKN
914178
In 2024, Surmodics's return on equity (ROE) was -0.01, a -94.91% increase from the -0.25 ROE in the previous year.
Surmodics Aktienanalyse
What does Surmodics do?
Surmodics Inc is an American company specializing in medical technology, based in Eden Prairie, Minnesota. They focus on developing and commercializing technologies to improve disease diagnosis and treatment. The company offers a wide range of medical devices and solutions for various medical applications, including cardiology, radiology, oncology, ophthalmology, and pharmaceutical development. Surmodics operates in three main business areas: medical devices, hollow fiber technology, and bioactive coatings. Their products are designed to meet the specific needs of customers and medical applications. Surmodics has a strong global presence and has expanded through strategic acquisitions in recent years, particularly in the pharmaceutical development and hollow fiber technology sectors. Surmodics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Surmodics's Return on Equity (ROE)
Surmodics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Surmodics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Surmodics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Surmodics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Surmodics stock
How has the Return on Equity (ROE) of Surmodics developed compared to the previous year?
The ROE of Surmodics has increased by -94.91% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Surmodics?
A high ROE indicates that Surmodics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Surmodics?
A low ROE can indicate that Surmodics is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Surmodics affect the company?
A change in ROE (Return on Equity) of Surmodics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Surmodics?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Surmodics?
Some factors that can influence Surmodics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Surmodics pay?
Over the past 12 months, Surmodics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surmodics is expected to pay a dividend of 0 USD.
What is the dividend yield of Surmodics?
The current dividend yield of Surmodics is .
When does Surmodics pay dividends?
Surmodics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Surmodics?
Surmodics paid dividends every year for the past 0 years.
What is the dividend of Surmodics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Surmodics located?
Surmodics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Surmodics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Surmodics from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did Surmodics pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of Surmodics in the year 2023?
In the year 2023, Surmodics distributed 0 USD as dividends.
In which currency does Surmodics pay out the dividend?
The dividends of Surmodics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Surmodics
Our stock analysis for Surmodics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surmodics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
